NCT06491004View on ClinicalTrials.gov

Evaluation of DiaSorin LIAISON® PTX3 (Long Pentraxin 3) Assay in Patients With Pneumonia

CompletedOBSERVATIONAL
Enrollment

281

Participants

Timeline

Start Date

September 20, 2021

Primary Completion Date

March 29, 2024

Study Completion Date

March 29, 2024

Conditions
Pneumonia
Interventions
DIAGNOSTIC_TEST

PTX3 assay

PTX3 dosage by the in vitro medical device in evaluation.

Trial Locations (2)

20089

Istituto Clinico Humanitas, Rozzano

24125

Cliniche Humanitas Gavazzeni, Bergamo

All Listed Sponsors
lead

Diasorin Italia S.p.A.

INDUSTRY

NCT06491004 - Evaluation of DiaSorin LIAISON® PTX3 (Long Pentraxin 3) Assay in Patients With Pneumonia | Biotech Hunter | Biotech Hunter